Phoenixville, PA, United States of America

Daniel Robert Sylvester


Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 83(Granted Patents)


Location History:

  • Collegeville, PA (US) (2001 - 2002)
  • Phoenixville, PA (US) (1999 - 2010)

Company Filing History:


Years Active: 1999-2010

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Daniel Robert Sylvester

Introduction

Daniel Robert Sylvester is a notable inventor based in Phoenixville, PA, with a remarkable portfolio of nine patents. His work primarily focuses on advancements in biotechnology, particularly in the development of therapeutic antibodies and polypeptides.

Latest Patents

Among his latest patents, Sylvester has developed recombinant IL4 antibodies that are useful in the treatment of IL4 mediated disorders. This includes chimeric and humanized IL4 monoclonal antibodies derived from affinity monoclonal antibodies, along with pharmaceutical compositions containing these antibodies and methods of treatment. Another significant invention is related to Defl polypeptides and DNA (RNA) encoding these polypeptides. This invention provides methods for producing such polypeptides through recombinant techniques and utilizes Defl polypeptides to screen for antibacterial compounds.

Career Highlights

Throughout his career, Sylvester has made significant contributions to the field of biotechnology. He has worked with prominent organizations such as SmithKline Beecham Corporation and the University of Vermont and State Agricultural College. His innovative work has paved the way for advancements in medical treatments and therapeutic applications.

Collaborations

Some of his notable coworkers include Mitchell Stuart Gross and Stephen Dudley Holmes, who have collaborated with him on various projects, enhancing the impact of his inventions.

Conclusion

Daniel Robert Sylvester's contributions to biotechnology through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence advancements in medical treatments and therapeutic innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…